Digital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)Clinical Development for Duchenne Muscular Dystrophy.
Antisense oligonucleotides (AONs) in clinical development for Duchenne muscular dystrophy (DMD) aim to induce skipping of a specific exon of the dystrophin transcript during pre-mRNA splicing. This results in restoration of the open reading frame and consequently synthesis of a dystrophin protein wi...
Main Authors: | Ruurd C Verheul, Judith C T van Deutekom, Nicole A Datson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5017733?pdf=render |
Similar Items
-
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
by: van Ommen Gert-Jan B, et al.
Published: (2007-07-01) -
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures.
by: Monika Hiller, et al.
Published: (2018-01-01) -
New Approach for Antisense Oligonucleotide-Mediated Exon Skipping in Duchenne Muscular Dystrophy.
by: Aoki, Y, et al.
Published: (2012) -
Challenges for antisense oligonucleotide-based therapeutics, in particular for exon 51-skipping in Duchenne muscular dystrophy
by: Aoki, Y, et al.
Published: (2011) -
In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
by: Wang, Q, et al.
Published: (2010)